burger

A pharmaceutical company
specialising in biological
medicinal products

3 fields of therapy
  • Immunology
  • Haemostasis
  • Intensive Care

Group executive committee

Committee’s composition
3

Bioproduction sites in France

2/3

of LFB’s products treat rare diseases

15 medicines

prescribed to

hospital

€ 400 M in turnover

in 2018

22

medical specialties that regularly use
LFB’s medicines

1 st in France

in the field
of plasma-derived
medicinal products

Meeting with

GHU Paris Psychiatrie & Neurosciences ,

" In the context of the Covid-19 pandemic, In the context of the Covid-19 pandemic, LFB supports GHU Paris. "

LFB announces FDA approval of SEVENFACT®, a recombinant coagulation Factor VIIa

All news

2:54

LFB's commitment to patients and to IRIS association.

2:56

LFB Arras plant under construction, in September 2019 in video

2:11

LFB Group corporate film 2019

Living with peripheral neuropathies, a video supported by LFB

All videos

LFB announces FDA approval of SEVENFACT®, a recombinant coagulation Factor VIIa

Presentation of the PRISM Study Results During the LFB Symposium at the ICNMD Virtual Congress

LFB symposium at the ISTH virtual congress on July 14th

Visit of the future LFB manufacturing site in Arras

Scientific publications for LFB

LFB SIGNS AGREEMENT WITH XENOTHERA TO MANUFACTURE FIRST CLINICAL BATCH OF XENOTHERA'S XAV-19 FOR THE TREATMENT OF CORONAVIRUS INFECTIONS INCLUDING COVID-19
15 medicines

prescribed to

hospital
3

Bioproduction sites in France
2/3

of LFB’s products treat rare diseases
1st in France

in the field
of plasma-derived
medicinal products

2:54

LFB's commitment to patients and to IRIS association.

there is 9 months

2:56

LFB Arras plant under construction, in September 2019 in video

there is 10 months

Living with peripheral neuropathies, a video supported by LFB

there is 2 years

2:11

LFB Group corporate film 2019

there is 5 years

Group executive committee

Committee’s composition